Synergetic hemostatic potential of fibrinogen γ‐chain peptide‐coated, adenosine 5′‐diphosphate‐encapsulated liposomes combined with whole blood transfusion: A preclinical study

Documenti analoghi

• Retention of critical platelet hemostatic functions of amotosalen‐ UVA pathogen‐reduced cryoprecipitated fibrinogen complex
  di: Florian Tupin, et al.
  Pubblicazione: (2026)
• Analyzing and modeling massive transfusion strategies and the role of fibrinogen—How much is the patient actually receiving?
  di: Nadia M. Keltner, et al.
  Pubblicazione: (2024)
• On lower fibrinogen threshold for fibrinogen replacement in plasma exchange: Perhaps for patients with no bleeding risk, but there are more shades of gray
  di: Matej Zrimsek, et al.
  Pubblicazione: (2025)
• The clinical use of cryoprecipitate and fibrinogen concentrate: A scoping review
  di: Aaron S. Hess, et al.
  Pubblicazione: (2026)
• Early cryoprecipitate transfusion through goal‐directed bleeding management in a real world setting—How important it is to focus on the fibrinogen in major obstetric Haemorrhage
  di: Ganesh Mohan, et al.
  Pubblicazione: (2026)